Compare Agilent Technologies Inc (A) vs D Wave Quantum Inc (QBTS) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Agilent Technologies Inc vs D Wave Quantum Inc — how do they compare? Agilent Technologies Inc trades at $129.02 (market cap $37.04B), while D Wave Quantum Inc trades at $20.5 (market cap $7.80B). The key difference: Agilent Technologies Inc is far larger — about 4.7× D Wave Quantum Inc's market cap, and Agilent Technologies Inc pays a 0.78% dividend while D Wave Quantum Inc pays none. Which is the better fit depends on your goals.
| A | QBTS | |
|---|---|---|
Market Cap | $37.04B | $7.80B |
Sector | Health | Technology |
52-Week High | $157.20 | $44.78 |
52-Week Low | $110.24 | $12.98 |
Enterprise Value | $38.59B | $7.26B |
Dividend Yield | 0.78% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Agilent Technologies (A) trades at $131.14, up 0.34% on the day, with a bearish technical signal but strong analyst support. The stock shows solid profitability with a net margin of 19.55% and ROE of 21.33%, supported by recent earnings beats. Recent acquisitions like Biocare Medical highlight growth initiatives, while cash flow trends remain positive. Valuation ratios such as P/E of 26.22 are elevated but align with quality growth expectations.
The outlook is positive given analyst consensus with a $154.90 price target and 77.5% buy ratings. Risks include execution of acquisitions and macroeconomic pressures on life sciences spending. The stock offers growth potential from AI-driven product launches, though technical resistance near $132 may cap near-term gains.
D-Wave Quantum (QBTS) trades at $22.56, up 0.11% on the day, amid a bearish technical signal from moving averages. The company reported a net loss of $355.06 million on $24.59 million revenue in 2025, with a negative net income margin of -2,957.23%. Recent positive developments include being named a Leader in the IDC MarketScape quantum computing assessment and securing a $1.5 million NSF grant.
Despite unanimous analyst buy ratings and a $39.86 consensus price target, significant risks include extreme cash burn, negative profitability, and the speculative nature of quantum computing commercialization. The stock's high P/S ratio of 619.05 reflects growth expectations but underscores valuation sensitivity to execution milestones.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Agilent Technologies Inc
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →About D Wave Quantum Inc
D-Wave Quantum Inc. is a global leader in the development and delivery of quantum computing systems, software, and services. The company specializes in annealing quantum computers designed to solve complex optimization problems across industries such as logistics, materials science, and financial modeling. D-Wave offers its technology through the cloud, allowing customers to build and run real-world quantum applications today, making it a key player in the commercialization of quantum computing.
Read more on QBTS →
